


Oncology
2024-08-30
GemPharmatech and Simcere Zaiming Pharmaceutical Co, Ltd. have collaborated on a newly published paper titled, "Technical considerations and strategies for generating and optimizing humanized mouse tumor models in immuno-oncology research," published in the academic journal International Immunopharmacology. Read more
GemPharmatech provided the BALB/c-hTNFR2 KI mice and CT26-hTNFR2 KI cell line in this study, as well as conducted the research of hTNFR2-GEMM.
| The hTNFR2-GEMM featured in the article |
Construction, characterization and validation of a hTNFR2-GEMM model

More infomation about blogs

Let us know which event you're attending and we'd be happy to connect with you.
This website will store cookies on your computer. These cookies are used to collect information about how you interact with this website and enable us to remember you. We use this information to improve and customize your browsing experience, as well as to analyze and collect relevant data and metrics about visitors on this website and other platforms. For more information about the cookies we use, please refer to our privacy policy
If you decline, your information will not be tracked when visiting this website. A cookie will be used in your browser to remember your preference settings that you have not accepted.
